Moreover, MCTS1 has been shown to exert oncogenic effects on breast cancer progression by affecting multiple cancer-related signaling pathways, including modulation of c-Myc translation (Tian et al., 2020), IL-6/IL-6R signaling pathway (Weng et al., 2019), and Src/p190B signaling pathway (Wu et al., 2014). This evidence concerns the gene ARHGAP5 and breast cancer.